Zambon is a leading pharmaceutical and chemical multinational. Founded in 1906 in Italy, Zambon operates directly on three continents – Europe, North & South America and Asia. It has 2500 employees spread in 14 countries and consolidated sales of €483m.
Zambon Company S.p.A. is the holding company of the Zambon Group, consisting of fine chemicals company ZaCh System, pharmaceuticals multinational Zambon S.p.A. and corporate venture specialist Z-Cube the corporate venture arm of the group which has launched three start-up companies — PharmEste s.r.l., SuppreMol GmbH and ProtAffin Biotechnologie AG.
Z-Cube is a corporate company of Zambon Company S.p.A. focused on DDT exploitation. They convert promising technologies from university laboratories or early start-ups into a number of commercial opportunities, to generate revenue growth for all parties involved.
ZaCh System’s expertise and proprietary patents in process chemistry are wide-ranging, extending from asymmetric transformation and resolution to solid state analysis and control, the multistep synthesis of complex APIs and separation and purification.
In recent years, Zambon has entered a new growth phase with a renewed path to provide innovative solutions to improve patients’ quality of life, with a specialization in treating severe diseases such as Parkinson’s and Cystic Fibrosis.